https://www.selleckchem.com/pr....oducts/LDE225(NVP-LD
Objectives Mixed dopamine and serotonin receptor antagonists (DSRAs) are associated with significant weight gain and its complications. Our aim was to evaluate the effectiveness of metformin in reducing body mass index (BMI) and metabolic parameters in children treated with DSRAs. Methods We report a naturalistic study of 49 children and adolescents (mean age 14.9 ± 3.7 years), with BMI 85 percentile for age, treated with DSRAs during 2018-2020 in a child psychiatry clinic. Clinical data, anthropometric measurements, and
Like
Comment
Share
